De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.
Auteurs : Conte B, Soldato D, Razeti MG, Fregatti P, de Azambuja E, Schettini F, Prat A, Del Mastro L, Lambertini M Année : 2022 Journal : Clin Breast Cancer
Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients.
Auteurs : Franzoi MA, Lambertini M, Ceppi M, Bruzzone M, de Azambuja E Année : 2022 Journal : Breast Cancer Res Treat
Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and Ligibel.
Auteurs : Martel S, Lambertini M, de Azambuja E Année : 2022 Journal : J Natl Compr Canc Netw
How we treat patients with metastatic HER2-positive breast cancer.
Auteurs : Nader-Marta G, Martins-Branco D, de Azambuja E Année : 2022 Journal : ESMO Open
Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated with Radiation Therapy and Trastuzumab.
Auteurs : Bachir B, Anouti S, Jaoude JA, Kayali M, Tfayli A, de Azambuja E, Poortmans P, Zeidan Y Année : 2022 Journal : Int J Radiat Oncol Biol Phys